FDA Investigator Mindy M Chou

Mindy M Chou has inspections in 5 countries as of 27 Oct 2023. Mindy M Chou has collaborated with a combinined 6329 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
98
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100004351
Country:
United States of America, Canada, Italy, Germany, Taiwan
Co-Investigator(s):
Adetutu M Gidado, Alan L Truong, Alan P Kurtzberg, Alice S Tsao, Althea A Williams, Amatul H Marium, Anastasia M Shields, Andrew M Abramowitz, Anissa M Vargas, Anita R Michael, Anitha P Govada, Ann M Stewart, Ann Marie Montemurro, Anne Marie Russell, Annemarie Bodnar, Arduino Frankovic, Arthur G Hurst, Ashar P Parikh, Ashley Polizzotto, Atul J Agrawal, Barbara J Wilimczyk, Barbara Janine Breithaupt, Barbara Jwilimczyk Macri, Benton M Ketron, Bijoy Panicker, Bo Chi, PhD, Brandon L Mariner, Brandy N Lepage, Brenda W Uratani, PhD, Brian D Nicholson, Brian J Ryan, Brooke K Higgins, Bruce G Cooper, Bryan A Galvez, Candace Y Gomez Broughton, Carl A Huffman, III, Carl A Perez, Carolyn J Cook, Caryn M Mcnab, Cassandra L Abellard, Cedar H Boakye, Charanjeet Jassal, Charisse K Green, Charles M Edwards, Christina K Theodorou, Christine A Harman, PhD, Christopher Janik, Christopher S Fields, Claire O Nicholls, Cody D Rickman, Collins, Cynthia J Lee, MS, Daniel J Grabicki, Daniel L Zheng, David A Oluwo, David J Hafner, David L Chon, David R Delucia, Demitria J Argiropoulos, Demitria J Xiradakis, Denise L Terzian, Dennis E Guilfoyle, PhD, Diane E Bruce, Dien N Nguyen, Dipesh K Shah, Djamila Harouaka, Donald G Gordon, Donald L Lech, Dongping Dai, PhD, Dr. Robert C Horan, MD, Dr. Yubing Tang, Edmund F Mrak, Jr, Emest F Bizjak, Emmanuel Adu Gyamfi, Eric L Dong, BS, Eric Rothschild, Erik W Koester, Erika E Englund, PhD, Erin L Nagel, Esaw, Felix Maldonado, Frank Verni, Frank W Perrella, Gale L Glinecki, Gam S Zamil, Ganesh N Joshi, Gary J Lehr, Gary T Greco, Gregson A Joseph, Gregson Joseph, Guerlain Ulysse, Gwyn G Dickinson, Harry J Brewer, Helen B Ricalde, Helen Verdel, Ilana Zigelman, Iram R Hassan, PhD, Irina Gaberman, Ivis Lnegron Torres, J Paul Kirwan, PhD, Jacqueline Mdiaz Albertini, Jacqueline S Warner, James A Liubicich, James A Liubieich, James D Bridges, James M Mason, Jamie D Richardson, Janet A Rajan, Jason D Tenney, Jay T Wong, Jazmine N Brown, Jennifer D Hollstrom, Jens Fricke, Jesse P Hardin, Jessica L Pressley, Jie He, Joanne M Schlossin, Joel R Merriman, Jogy George, John A Podsadowski, John Dan, John M Gusto, John P Mistler, Johnna L Bleem, Jonathan G Matrisciano, Jonathan W Chapman, Jose Acruz Gonzalez, Jose M Cayuela, Jose O Hernandez, Jose R Hernandez, Joseph F Mcginnis, RPh, Joseph J Vannelli, Joseph Maselli, Joseph Mcginnis, Joseph R Lambert, Joy Rkozlowski Klena, Juan Rjimenez Garcia, Juanita P Versace, Juliana M Badalucco, Kalavati Suvarna, PhD, Kames A Liubicich, Karen A Briggs, Karen L Kosar, Karishma G Gopaul, Karl Auguste, Katherine E Jacobitz, Katherine Szestypalow, Kathleen M Jordan, Kathryn A Nagy, Kellie Leveille, Kenneth G Klobus, Kenneth H Williams, Kevin A Gonzalez, Kim Lthomas Cruse, Kim M Downing, Kim Thomasc Rice, Ko U Min, Krishna Ghosh, PhD, Kristina J Donohue, Kwong Lee, Kwong P Lee, L Gnnmassimia Massimilla, PharmD, Lakshmi Narasimhan, PhD, Lata C Mathew, PhD, Laura Fontan, MS, Lauren E Blaser, Laurissa S Flowers, Lawrence W Farina, LCDR Chad N Thompson, LCDR Susan E Polifko, LCDR Wilfred A Darang, Liatte Kreuger, PharmD, Lilia L Bi, Liming Zhang, Linda M Sacco, Lisa M Smith, LTJG Matthew R Palo, Manhar R Patel, Marcellinus D Dordunoo, Marcelo O Mangalindan, Jr, Marcia D Fields, Marcus A Ray, Margaret E Sarles, Margaret L Bolte, Margaret M Sands, Maria Joselopez Barragan, PhD, Marie Bbuen Bigornia, Marie Elena C Puleo, Marlene G Swider, Marlene L Davis, Mary F Finn, Mary Jeanet Mcgarry, Mary M Finn, Matthew A Sparato, Matthew A Spataro, Matthew D Schnittker, Maxwell Van Tassell, PhD, Melissa D Ray, Merideth K Rose, Michael A Charles, Michael E Maselli, Michael L Casner, Michael Levin, Michael Levine, Michael R Dominick, Michael R Goga, Michael R Klapal, Michael Shanks, MS, Michael W Burd, Michelle Y Clark Stuart, Mihaly S Ligmond, Milan S Mcgorty, Milos Dokmanovic, PhD, Mra Davism, Mra M Barbosar, Nancy A Saxenian Emmons, Nancy M Espinal, Nariman Patenaude, Natasha Gupta, Nazmul Hassan, Neal L Adams, Nealie C Newberger, Nebil A Oumer, Neil J Bonzagni, PhD MPH, Nicholas A Violand, Nicholas C Mendiola, Nicholas L Paulin, Nicole Vaught, Noreen Muniz, Obinna R Echeozo, Omotunde O Osunsanmi, Ou Ma, Pamela L Vega, Parul M Patel, Patrick C Klotzbuecher, Paul E Stein, Paul L Bellamy, Paul Mouris, Paula J Bretz, Pelekakis, Penny H Mccarver, Perry T Nichols, Peter Abel, Peter Caparelli, Peter M Trunk, Peter R Caparelli, Philip F Istafanos, DMV, MS, Preston M Lee, Pushpa S Jayasekara, Rachael A Moliver, Rachel C Harrington, Raihan A Chowdhury, Rajiv R Srivastava, Ramon A Hernandez, Rebecca Rodriguez, Regina T Brown, Reyes Candau Chacon, PhD, Richard Ferfoglia, Richard J Friedman, Richard L Friedman, Richard Ledwidge (nmi), PhD, Rober C Horan, PhD, Robert C Howard, Robert C Steyert, Robert E Moncayo, Robert J Maffei, Robert J Martin, Robert J Veitch, Robin P Mathew, Rochelle K Kimmel, Rose Xu, Roseline N Boateng, Ruben C Quintana, Russ E Davis, Russell J Glapion, S Lori Brown, PhD MPH, Samina S Khan, Samir C Gala, Samuel T Walker, Sandra D Thompson, Sangeeta M Khurana, PhD, Sarah A Meehan, Sarah A Wangseng, Sarah Kennett, PhD, Satheesh Thomas, Sayyem H Akbar, Scott T Ballard, Sena G Dissmeyer, Shari L Kahn, Shirley J Berryman, Shreya Shah, Shusheen A Alexander, Sidney B Priesmeyer, Simone E Pitts, Sony Mathews, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, State Agency, Stephen D Brown, Steven A Gonzales, Steven C Madzo, Steven J Libal, Steven M Weinman, Steven P Donald, Susan F Laska, MS, Susan M Jackson, Susan P Bruederle, Susanna E Ford, Analyst, Syeda N Mahazabin, Tajah L Blackburn, Tamara L Ely, Tamara N Champion, Tamil Arasu, PhD, Tammy Notto, Tammy S Notto, Tanya R Syffrard, Tara K Carmody, Tekalign Wondimu, Terry Bridgewater, Thomas J Arista, Thomas J Mooney, Thomas P Hansen, Thomas S Arista, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Tiki J Dixon, Tzanko Stantchev, Uduak M Inokon, Unnee Ranjan, Valentino Fiorella, Valerie A Potopsingh, Victoria Spivak, Vioela J Caze, Viviana Matta, Vivin George, Warren J Lopicka, Wayne D Mcgrath, Wayne E Seifert, Wayne S Fortenberry, Wendy G Tan, PhD, William J Leonard, William M Rennells, Willie Wilson, Xiaokuang Lai, PhD, Xikui Chen (nmi), PhD, Young M Yoon, Yumi J Hiramine, Yvonne M Santiago, Zakaria I Ganiyu, Zhihao Qiu (Peter), PhD, Zhong Li, PhD

Mindy M Chou's Documents

Publish Date Document Type Title
November, 2022 FDA 483 Advanced Accelerator Applications USA, Inc. - Form 483, 2022-11-03
August, 2014 FDA 483 POLYGEN PHARMACEUTICALS INC. - Form 483, 2014-08-29
June, 2015 FDA 483 Strides Pharma, Inc - Form 483, 2015-06-04
June, 2017 FDA 483 Boothwyn Pharmacy LLC - Form 483, 2017-06-16
December, 2015 FDA 483 Professional Disposables International, Inc. - Form 483, 2015-12-09
October, 2019 FDA 483 Regeneron Pharmaceuticals, Inc. - Form 483, 2019-10-18
January, 2019 FDA 483 Perrigo New York, Inc. - Form 483, 2019-01-22
December, 2018 FDA 483 SOFIE Co. dba SOFIE - Form 483, 2018-12-03
August, 2016 FDA 483 Response Syntho Pharmaceuticals Inc. - Form 483R, 2016-08-26
August, 2015 FDA 483 The Estee Lauder Inc - Form 483, 2015-08-06
December, 2018 FDA 483 Response SOFIE Co. dba SOFIE - Form 483R, 2018-12-21
November, 2016 EIR AMA Laboratories, Inc. - EIR, 2016-11-17
February, 2022 FDA 483 WES PHARMA INC - Form 483, 2022-02-18
October, 2019 EIR Regeneron Pharmaceuticals, Inc. - EIR, 2019-10-18
September, 2014 EIR P & L Development, LLC - EIR, 2014-09-17
September, 2020 FDA 483 Healthy Choice Compounding LLC - Form 483, 2020-09-24
November, 2019 FDA 483 Catalent Maryland, Inc. - Form 483, 2019-11-04
November, 2022 EIR Advanced Accelerator Applications USA, Inc. - EIR, 2022-11-03
August, 2016 FDA 483 Syntho Pharmaceuticals Inc. - Form 483, 2016-08-26
September, 2014 FDA 483 P & L Development, LLC - Form 483, 2014-09-17
October, 2016 FDA 483 Cosco Enterprises, Inc - Form 483, 2016-10-27
March, 2019 FDA 483 NIH Clinical Center Pharmacy Department - Form 483, 2019-03-06
November, 2015 FDA 483 Chartwell Pharmaceuticals Carmel, LLC - Form 483, 2015-11-02
November, 2019 FDA 483 Response Catalent Maryland, Inc. - Form 483R, 2019-11-25
August, 2022 FDA 483 RK PHARMA INC. - Form 483, 2022-08-12
May, 2019 FDA 483 Professional Disposables International, Inc. - Form 483, 2019-05-28
October, 2022 FDA 483 Steri-Pharma, LLC - Form 483, 2022-10-04
February, 2020 FDA 483 Holopack Verpackungstechnik GmbH - Form 483, 2020-02-18
March, 2021 FDA 483 Norwich Pharmaceuticals, Inc. - Form 483, 2021-03-16
November, 2017 FDA 483 BASF Corporation - Form 483, 2017-11-17
February, 2017 FDA 483 Healthy Choice Compounding LLC - Form 483, 2017-02-28
November, 2014 FDA 483 Ultra Seal Corporation - Form 483, 2014-11-12
June, 2018 FDA 483 Cosmetica Laboratories Inc. - Form 483, 2018-06-01
January, 2017 FDA 483 HomeoCare Laboratories Inc. - Form 483, 2017-01-11
April, 2019 FDA 483 Hercon Pharmaceuticals LLC - Form 483, 2019-04-05
September, 2022 FDA 483 ScieGen Pharmaceuticals, INC. - Form 483, 2022-09-02
December, 2018 EIR SOFIE Co. dba SOFIE - EIR, 2018-12-03
October, 2021 FDA 483 Berkshire Sterile Manufacturing, Inc. - Form 483, 2021-10-15
March, 2017 EIR Fresenius Kabi USA, LLC - EIR, 2017-03-30
October, 2021 EIR Berkshire Sterile Manufacturing, Inc. - EIR, 2021-10-15
June, 2016 FDA 483 Kings Park Slope Inc - Form 483, 2016-04-22
November, 2022 FDA 483 Response Advanced Accelerator Applications USA, Inc. - Form 483R, 2022-11-03
August, 2016 EIR Amneal Pharmaceuticals of New York, LLC - EIR, 2016-08-09
August, 2016 FDA 483 Amneal Pharmaceuticals of New York, LLC - Form 483, 2016-08-09
December, 2019 EIR Chartwell Pharmaceuticals Carmel, LLC - EIR, 2019-12-16
July, 2015 FDA 483 MANA PRODUCTS, INC. - Form 483, 2015-07-10
October, 2021 FDA 483 Response Berkshire Sterile Manufacturing, Inc. - Form 483R, 2021-10-15
July, 2021 FDA 483 Reliant Compounded Solutions Monroe, LLC - Form 483, 2021-07-27
September, 2018 FDA 483 ULTRAtab Laboratories, Inc. - Form 483, 2018-09-14
December, 2017 FDA 483 NCM USA Bronx LLC - Form 483, 2017-12-08
May, 2017 FDA 483 InvaGen Pharmaceuticals, Inc - Form 483, 2017-05-26
May, 2023 FDA 483 Patheon Italia S.p.A. - Form 483, 2023-05-26
May, 2015 FDA 483 Cerovene, Inc. - Form 483, 2015-05-04
December, 2016 FDA 483 Magellan Rx Pharmacy, LLC - Form 483, 2016-12-22
April, 2021 FDA 483 J.M. Murray Center, Inc. - Form 483, 2021-04-30
March, 2022 FDA 483 Precision Nuclear of Virginia - Form 483, 2022-03-25
January, 2022 FDA 483 Zennova LLC - Form 483, 2022-01-27
February, 2017 FDA 483 Cerovene, Inc. - Form 483, 2017-02-08
November, 2016 FDA 483 Fougera Pharmaceuticals Inc. - Form 483, 2016-11-10
November, 2015 EIR Chartwell Pharmaceuticals Carmel, LLC - EIR, 2015-11-02
September, 2018 EIR ULTRAtab Laboratories, Inc. - EIR, 2018-09-14
March, 2023 FDA 483 Delsam Pharma LLC - Form 483, 2023-03-24
October, 2016 FDA 483 American Cleaning Solutions - Form 483, 2016-10-14
December, 2019 FDA 483 Response Chartwell Pharmaceuticals Carmel, LLC - Form 483R, 2020-01-06
July, 2016 FDA 483 Chartwell Pharmaceuticals Amityville, LLC. - Form 483, 2016-07-15
December, 2019 FDA 483 Chartwell Pharmaceuticals Carmel, LLC - Form 483, 2019-12-16
May, 2016 FDA 483 Equibal, Inc. - Form 483, 2016-05-27
January, 2017 FDA 483 Response HomeoCare Laboratories Inc. - Form 483R, 2017-03-01
March, 2015 FDA 483 InvaGen Pharmaceuticals, Inc - Form 483, 2015-03-13
October, 2014 FDA 483 Spa Technologies International Inc - Form 483, 2014-10-03
December, 2021 EIR Aphena Pharma Solutions - Maryland, LLC - EIR, 2021-12-15
November, 2019 EIR Catalent Maryland, Inc. - EIR, 2019-11-04
February, 2017 EIR Cerovene, Inc. - EIR, 2017-02-08
October, 2023 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2023-10-13
August, 2019 FDA 483 SSM Health Care St. Louis DBA SSM St. Clare Health Center - Form 483, 2019-08-28
July, 2016 FDA 483 Grace, William R M.D. - Form 483, 2016-07-08
May, 2017 EIR InvaGen Pharmaceuticals, Inc - EIR, 2017-05-26
May, 2021 FDA 483 Pine Pharmaceuticals, LLC - Form 483, 2021-05-14
December, 2018 FDA 483 Nutravail LLC - Form 483, 2018-12-07
October, 2015 FDA 483 Pine Pharmaceuticals, LLC - Form 483, 2015-10-09
March, 2017 FDA 483 Fresenius Kabi USA, LLC - Form 483, 2017-03-30
May, 2022 FDA 483 Akorn Operating Company LLC (dba Akorn) - Form 483, 2022-05-17
March, 2015 EIR InvaGen Pharmaceuticals, Inc - EIR, 2015-03-13
December, 2017 EIR NCM USA Bronx LLC - EIR, 2018-01-17
December, 2021 FDA 483 Aphena Pharma Solutions - Maryland, LLC - Form 483, 2021-12-15

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more